SGS To Host A Webinar to Provide Guidance on Post-Brexit Regulatory Compliance for Medical Devices
From 1 January 2021, the responsibilities for the UK medical devices market that are currently governed by the European Union (EU) will be taken over by the Medicines and Healthcare Products Regulatory Agency (MHRA).
All manufacturers wishing to place a medical device, in vitro diagnostic or custom-made device on the UK market will will have a grace period to register with the MHRA. The new UK regulation and UKCA (UK Conformity Assessed) mark will then apply.
However, the MHRA will continue to recognize devices with CE marks and certificates issued by European Economic Area-based Notified Bodies until 30 June 2023.
This webinar with provide information on:
- How to place medical devices on the UK market after 1 January 2021
- How UK medical device manufacturers can continue to supply to the EU market from 1 January 2021
- When to register a medical device with the MHRA
- Understand vigilance, labelling and role of a UK Responsible Person
- Key dates
Can't make the live session? Register now and receive a complimentary recording after the live event.
For more information, please contact:
t: +44 (0)1276 697 715
SGS is the world's leading inspection, verification, testing and certification company. SGS is recognised as the global benchmark for quality and integrity. With more than 89,000 employees, SGS operates a network of over 2,600 offices and laboratories around the world.